Stephen J. Forman
2021
In 2021, Stephen J. Forman earned a total compensation of $443.9K as Director at LIXTE BIOTECHNOLOGY HOLDINGS.
Compensation breakdown
| Option Awards | $427,047 |
|---|---|
| Other | $16,819 |
| Total | $443,866 |
Forman received $427K in option awards, accounting for 96% of the total pay in 2021.
Forman also received $16.8K in other compensation.
Rankings
In 2021, Stephen J. Forman's compensation ranked 10,976th out of 12,415 executives tracked by ExecPay. In other words, Forman earned more than 11.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,976 out of 12,415 | 12th |
Division Manufacturing | 4,845 out of 5,505 | 12th |
Major group Chemicals And Allied Products | 2,164 out of 2,375 | 9th |
Industry group Drugs | 1,925 out of 2,096 | 8th |
Industry Pharmaceutical Preparations | 1,425 out of 1,546 | 8th |
Source: SEC filing on November 4, 2024.
Forman's colleagues
We found five more compensation records of executives who worked with Stephen J. Forman at LIXTE BIOTECHNOLOGY HOLDINGS in 2021.